Patent · US Active

Short interfering nucleic acid (siNA) compositions

US11530407B2 · kind B2 · utility

0Cited by
24References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 18, 2020
Grant dateDec 20, 2022
Priority date
Expiry dateFeb 18, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/51
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds, compositions, and methods for the study, diagnosis, and treatment of traits, diseases and conditions that respond to the modulation of gene expression and/or activity, and/or modulate a gene expression pathway. Specifically, the invention relates to double-stranded nucleic acid molecules including small nucleic acid molecules, such as short interfering nucleic acid (siNA) molecules that are capable of mediating or that mediate RNA interference (RNAi) against target gene expression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.